Pieris Pharmaceuticals (NASDAQ:PIRS) reported its Q1 earnings results on Wednesday, May 10, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Pieris Pharmaceuticals missed estimated earnings by 28.57%, reporting an EPS of $-0.18 versus an estimate of $-0.14.
Revenue was down $9.05 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.12 which was followed by a 2.83% drop in the share price the next day.
Here’s a look at Pieris Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.23 | -0.16 | -0.11 | -0.11 |
| EPS Actual | -0.11 | -0.13 | -0.14 | -0.07 |
| Revenue Estimate | 6.51M | 2.26M | 10.47M | 11.30M |
| Revenue Actual | 5.85M | 5.37M | 3.70M | 10.99M |
To track all earnings releases for Pieris Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
